Patey O, Bimet F, Riegel P, Halioua B, Emond J P, Estrangin E, Dellion S, Alonso J M, Kiredjian M, Dublanchet A, Lafaix C
Department of Infectious and Tropical Diseases, Villeneuve St. Georges Hospital, France.
J Clin Microbiol. 1997 Feb;35(2):441-5. doi: 10.1128/jcm.35.2.441-445.1997.
Diphtheria is a disease with a long history that almost completely disappeared from developed countries. In addition, until 1987, systemic infections involving Corynebacterium diphtheriae were rare. However, in 1990, an epidemic occurred in Russia. These two circumstances have provided the stimulus to gain insight into the situation in France. In fact, between 1987 and 1993, a total of 59 C. diphtheriae strains were isolated. Epidemiological data were collected for patients from whom 40 strains were isolated from normally sterile sites, including 34 from blood cultures, and half of the bacteremic patients developed endocarditis. Osteoarticular involvement was noted in 11 of these 40 patients, including 5 bacteremic patients. The fatality rate following bacteremia was 36%, despite specific antibiotic treatment (beta-lactams and aminoglycosides). The mean age of the participants was 38 years, with half of the patients subsisting under low socioeconomic conditions and suffering from homelessness or alcoholism. Apparently, the skin turned out to be the major route of transmission in this reemerging disease. Eighty-eight percent of the isolates belonged to the C. diphtheriae biotype mitis. These were found predominantly in the Paris area, and most were of the same ribotype. Those isolates originating from the overseas territories (Guyana and New Caledonia) belonged to C. diphtheriae biotype gravis. No strains were positive for the tox gene by PCR. This study attests to the persistent circulation in France of C. diphtheriae in the form of systemic infections. The matter is especially significant since these strains are nontoxigenic and are of a unique ribotype. The strains are, however, sensitive to most antibiotics, although 20% are rifampin resistant.
白喉是一种历史悠久的疾病,在发达国家几乎已完全消失。此外,直到1987年,涉及白喉棒状杆菌的全身感染都很罕见。然而,1990年俄罗斯发生了疫情。这两种情况促使人们深入了解法国的情况。事实上,1987年至1993年间,共分离出59株白喉棒状杆菌菌株。收集了从正常无菌部位分离出40株菌株的患者的流行病学数据,其中34株来自血培养,半数菌血症患者发生了心内膜炎。这40名患者中有11名出现骨关节受累,其中5名是菌血症患者。尽管进行了特异性抗生素治疗(β-内酰胺类和氨基糖苷类),菌血症后的死亡率仍为36%。参与者的平均年龄为38岁,半数患者生活在社会经济条件低下的环境中,患有无家可归或酗酒问题。显然,在这种重新出现的疾病中,皮肤成为了主要传播途径。88%的分离株属于轻型白喉棒状杆菌生物型。这些菌株主要在巴黎地区发现,且大多数属于同一核糖型。那些来自海外领地(圭亚那和新喀里多尼亚)的分离株属于重型白喉棒状杆菌生物型。通过聚合酶链反应(PCR)检测,没有菌株的毒素基因呈阳性。这项研究证明白喉棒状杆菌在法国以全身感染的形式持续传播。鉴于这些菌株不产毒素且具有独特的核糖型,这一问题尤为重要。不过,这些菌株对大多数抗生素敏感,尽管有20%对利福平耐药。